Mechanisms of cardiovascular impact of SGLT2 inhibitors.
Session:
How do SGLT2 inhibitors and incretin-based therapy exert their effects on cardiovascular disease?
Topic:
Diabetes and the Heart
Event:
ESC Congress 2018
Congress Presentation
About the speaker
Professor Bart Staels
Lille Cedex (France)
1
presentation
0
follower
3 more presentations in this session
Epigenetic signatures and cardiovascular risk in diabetes.
Speaker: Professor F. Cosentino (Stockholm, SE)
Access the full session
How do SGLT2 inhibitors and incretin-based therapy exert their effects on cardiovascular disease?
Speakers:
Professor B. Staels, Professor F. Cosentino, Professor L. Ryden, Professor E. Ferrannini
About the event
ESC 365 is supported by
